Table 1.
Demographic and laboratorial characteristics of the study individuals according to transmitted drug resistance (TDR).
| TDR (n = 33) | Without TDR (n = 192) | Total (n = 225) | |
|---|---|---|---|
| Age (year old) | 32 (29–40) | 34 (29–40) | 34 (29–40) |
| Gender (male) | 23 (69.7%) | 138 (71.9%) | 161 (71.6%) |
| CD4+ T cells (cells/mm3) | 461 (322–631) | 475 (353–623) | 463 (344–626) |
| Viral load (Log10) | 4.1 (3.6–4.8) | 4.3 (3.6–4.7) | 4.3 (3.6–4.7) |
| HIV exposure | |||
| MSM | 20 (61%) | 100 (51%) | 120 (52%) |
| Heterosexual | 11 (33%) | 76 (41%) | 87 (40%) |
| IDU | 1 (33%) | 1 (0.5%) | 2 (0.4%) |
| HIV-1 subtype (partial pol) | |||
| A1 | 0 | 1 (0.5%) | 1 (0.4%) |
| B | 31 (94%) | 149 (78%) | 180 (76%) |
| F | 0 | 14 (7%) | 14 (6%) |
| C | 1 (33%) | 15 (8%) | 16 (7%) |
| CRF02_AG | 0 | 1 (0.5%) | 1 (0.4%) |
| Recombinant mosaic | 1 (33%) | 12 (6%) | 13 (6%) |
| Surveillance site | |||
| Campinas | 26 (79%) | 130 (68%) | 156 (69%) |
| São Paulo | 7 (21%) | 62 (32%) | 69 (31%) |